Overall rank by patents
#1,587
Across all tracked assignees
USPTO PatentsView assignee record - 261 granted patents across 70 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: Y02E (REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION).
The verdict
Sharp holds 261 US patents across 70 technology areas, rank #1,587 of 50,000 tracked assignees.
Sharp Laboratories Of America, Inc. has been granted 261 US utility patents between 2015 and 2022, placing Sharp Laboratories Of America, Inc. at rank #1,587 across all assignees tracked by PlainPatent. This portfolio spans 70 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in Y02E (REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION). As a US Corporation, Sharp Laboratories Of America, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Sharp sits between Unisantis Electronics Singapore PTE. Ltd. (262 patents, rank #1,583) and Apex Brands, Inc. (259 patents, rank #1,591) - the closest US assignees by grant volume. The composite Innovation Score of 54.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 14 grants, compared with 247 in the 2015–2019 window, a -94% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Sharp Laboratories Of America, Inc.'s 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 70 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sharp Laboratories Of America, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
UNISANTIS ELECTRONICS SINGAPORE PTE. LTD.
262 patents
Beth Israel Deaconess Medical Center, Inc.
261 patents
EMEMORY TECHNOLOGY INC.
261 patents
KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION
261 patents
Sharp Laboratories of America, Inc.
261 patents
Brocade Communications Systems LLC
260 patents
EAGLE TECHNOLOGY, LLC
260 patents
THERMO FISHER SCIENTIFIC (BREMEN) GMBH
260 patents
Apex Brands, Inc.
259 patents
What this shows Sharp holds 261 patents at rank #1,587, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,587 in granted patent volume.
Other assignees with the most granted patents in Sharp's primary technology class.
Sharp's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 82 | 31.4% |
| 2016 | 58 | 22.2% |
| 2017 | 64 | 24.5% |
| 2018 | 25 | 9.6% |
| 2019 | 18 | 6.9% |
| 2020 | 10 | 3.8% |
| 2021 | 2 | 0.8% |
| 2022 | 2 | 0.8% |
Top 15 of 70 technology areas
Overall rank by patents
#1,587
Across all tracked assignees
54.3 out of 100
How to use this portfolio
Sharp's 261 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.